N-Myristoyltransferase (NMT) isozymes, i.e., NMT1 and NMT2, are essential host factors for the AIDScausing human immunodeficiency virus type-1 (HIV-1), by which the viral proteins Pr55 gag and Nef are N-myristoylated. N-Myristoylation is important for the membrane targeting of modified proteins. Since it is predicted that approximately 0.5% of all proteins in the human genome are N-myristoylated, selective inhibition of closely HIV-1-associated NMT isozymes is thought to be important for the improvement of specificity in the anti-HIV-1 strategy with the inhibition of NMT function. NMT isozymes contain two characteristic structures, the N-terminal region and the catalytic region. Here, it was shown that the N-terminal region of each NMT isozyme is required for isozyme-specific binding to the ribosome. The specific binding of each isozyme to the ribosome was associated with HIV-1 production, in which NMT1 and NMT2 in the ribosome were suggested to be mainly related to Pr55 gag and Nef, respectively. These results indicate that the N-terminal region that mediates binding to the ribosome can become a target for NMT-isozyme-specific inhibition, which could block HIV-1 production.
; this modification is called protein N-myristoylation.
2) The consensus sequence of peptide substrates for NMT is known, in which N-terminal Gly at position two is absolutely required. 1, 3) N-Myristoylation is important for the membrane targeting of modified proteins.
N-Myristoylation occurs cotranslationally 4) and post-translationally. 5) Cotranslational N-myristoylation usually occurs at Gly exposed after the removal of the initiator Met from the nascent peptide with the consensus sequence. 6) Post-translational N-myristoylation also occurs at Gly exposed in caspase-cleavaged proteins with the consensus sequence. 5) Many viral proteins in addition to cellular proteins are N-myristoylated. 6, 7) N-Myristoylation occurs in products from the AIDS-causing human immunodeficiency virus type-1 (HIV-1) genome; Pr55 gag8) and Nef. 9) Pr55 gag is a precursor form of structural proteins of HIV-1 and its N-myristoylation is essential for the production of virions. 8) Nef is an accessory protein of HIV-1 and its N-myristoylation is essential for its multiple functions leading to the enhancement of viral replication. 10) In humans, NMT consists of multiple isozymes encoded by NMT1 11) and NMT2. 12) These NMT isozymes contain two characteristic structures, the N-terminal region and the catalytic region. The NMT1 family consists of a few isozymes with different lengths of the N-terminal region. 13) It has been suggested that each NMT isozyme has a specific role in vivo. 14, 15) Additionally, siRNA using studies suggested that NMT1 and NMT2 are respectively associated with the membrane targeting of Pr55 gag and Nef. 16, 17) In a previous study of the NMT1 isozyme, it was reported that the N-terminal region is not required for the catalytic activity 11) but is associated with ribosomal targeting. 18) However, it remains to be elucidated whether the N-terminal region differs in property in between NMT1 and NMT2. It was therefore hypothesized that the N-terminal region of each NMT isozyme is associated with a specific role of each NMT isozyme in the ribosome.
In this study, it was clarified that the N-terminal regions in both NMT isozymes are sufficient for binding to the ribosome, in which each basic-amino-acid-rich cluster sequence, named the K box, is essential for the binding. The catalytic region-deleted NMT mutants, NMTDCs, affected the bindings of endogenous NMTs, which resulted in relative reduction of endogenous NMTs in ribosome fraction. Furthermore, the coexpression of NMTDCs induced significant reduction of HIV-1 production. These results suggest that the bindings of endogenous NMTs to ribosome could be associated with effective HIV-1 production, which led us to hypothesize that such bindings can become a target for inhibition of HIV-1 replication.
MATERIALS AND METHODS

Materials
The infectious HIV-1 expression vector pNL-CH was kindly gifted by Dr. Ron Swanstrom of the UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC. Dulbecco's modified Eagle's medium (DMEM) was gifted from Nissui Pharmaceutical Co., Ltd.
Construction of Each NMT Isozyme and Mutant Expression Vectors The expression vectors for the NMT1DC, NMT2DC, NMT2DCDKbox, and NMT1LDCDKbox proteins, which are tagged with a V5 epitope at the C-terminus, were constructed using polymerase chain reaction (PCR) and standard subcloning techniques. The V5 epitope tag sequence is GKPIPNPLLGLDST, which is from V protein and phosphoprotein of simian virus 5. The PCR products coding NMT1DC and NMT2DC were subcloned into the pcDNA4/HisMax vector (Invitrogen, Carlsbad, CA, U.S.A.) for its expression in mammalian cells. -to-Ala 2 (G2A) mutation in gag and nef was introduced into the infectious molecular clone pNL-CH 19) derived from the pNL4-3 clone using the site-directed mutagenesis method. The mutant constructs were designated pNL-CH/ gagG2A, pNL-CH/nefG2A and pNL-CH/gagG2A/nefG2A.
Preparation of Cytosolic and Ribosomal Fractions
To separate the cytosolic fraction and the ribosomal fraction in the human embryonic kidney (HEK)293 cells used in the studies, the homogenates of the cells were subjected to subcellular fractionation using sequential differential centrifugation, as previously described. 18) To comparison of distribution of NMTs between ribosomal fraction and cytosolic fraction, same percentage of volume of each fraction was subjected to the western blot analysis.
Quantification of HIV-1 p24 Antigen in Supernatant Each NMT mutant protein expressing HEK293 cells (1.0ϫ10 6 cells) were cultured in six-well plates overnight. Confluent cells (30-50%) were transfected with each HIV-1 expression vector (pNL-CH, pNL-CH/gagG2A, pNL-CH/ nefG2A, and pNL-CH/gagG2A/nefG2A) using Lipofectamine TM LTX. After 48-h cultivation, the level of HIV-1 p24 antigen in the cell-free supernatant was measured using an enzyme-linked immunosorbent assay (ELISA) kit (ZeptoMetrix Corporation, Buffalo, NY, U.S.A.), according to the manufacturer's instruction.
Cell Lysis and Western Immunoblot Analysis The cells were washed, lysed and subjected to Western blot analysis.
16) The serum and antibodies used in different immunoblottings were as follows: anti-V5 (Invitrogen, Carlsbad, CA, U.S.A.), anti-lactate-dehydrogenase (Chemicon, Temecula, CA, U.S.A.), anti-NMT1 (BD Pharmingen, San Diego, CA, U.S.A.), and anti-NMT2 (BD Pharmingen, San Diego, CA, U.S.A.) antibodies. Immune complexes were detected with appropriate peroxidase-conjugated secondary antibodies followed by visualization by chemiluminescence detection (NEN Life Science Products, Boston, MA, U.S.A.).
RNA Extraction and Detection of 28S Ribosomal RNA (rRNA) Total RNA from each fraction was extracted using Isogen (NIPPON GENE Co., Ltd., Tokyo, Japan). The extracted RNA was subjected to agarose gel electrophoresis and stained with ethidium bromide.
RESULTS AND DISCUSSION
The details of catalytic region of NMT have been well understood, in which there are the binding sites for myristoylCoA and peptide substrate. 20) On the other hand, the N-terminal region of NMT remains to be elucidated. Figure 1A illustrates that the NMT isozymes consist of an N-terminal region and a catalytic region, except for NMT1 short form (NMT1S) that contains no N-terminal region. It has not been confirmed whether endogenous NMT1 and endogenous NMT2 could actually localize to ribosome in addition to cytosol. Hence, the subcellular localization of endogenous NMT isozymes in HEK293 cells was analyzed using anti-NMT1 and NMT2 antibodies. Lactate dehydrogenase (LDH) and 28S ribosomal RNA were detected as cytosolic and ribosomal markers, respectively. As shown in Fig. 1B , NMT1 and NMT2 were detected in both cytosolic and ribosomal fractions; on the other hand, NMT1S was detected in only the cytosolic fraction. It was confirmed that endogenous NMT isozymes with the N-terminal region localize to the ribosome in addition to the cytosol, suggesting that N-terminal regions are associated with ribosomal targeting.
The N-terminal region has been suggested to be responsible for the ribosomal targeting of both NMT isozymes. Additionally, note that a unique sequence exists within the N-terminal region of each NMT isozyme, which consists of a basic-amino-acid-rich cluster sequence, named K box (Fig.  1A) . To determine whether each N-terminal region is sufficient and whether the K box is important for ribosomal localization in both NMT isozymes, the ability of ribosomal localization of the catalytic-region-deleted NMT1 and NMT2 mutants with or without the K box ( Fig. 2A) was examined. As shown in Fig. 2B , both NMT1DC and NMT2DC were detected in the both ribosomal and cytosolic fractions, The ribosomal and cytosolic fractions were isolated from HEK293 cells by differential centrifugation. The fractions were subjected to Western blot analysis using anti-NMT1 and anti-NMT2 antibodies. LDH was detected using a specific antibody as the cytosolic marker. RNA was isolated from the fractions and subjected to agarose electrophoresis, and stained with ethidium bromide. Cyto., cytosol fraction; Ribo., ribosomal fraction.
whereas both NMT1DCDKbox and NMT2DCDKbox were detected in only the cytosolic fraction. Both exogenous full length NMT1 and NMT2 were also detected in the both ribosomal and cytosolic fractions, in which the amounts of NMT1 and NMT2 in ribosomal fractions were relatively higher than those in cytosolic fractions. The results were identical to the endogenous NMT1 and NMT2 distribution. It was also shown that the ability of distribution to ribosome of each full-length isozyme was lost by deletion of the K box (Fig. 2C) , which results were identical to the distributions of the NMT1DCDKbox and NMT2DCDKbox (Fig. 2B) . The results indicate that the N-terminal region is sufficient and the K box is required for the ribosomal localization in both NMT1 and NMT2.
The identity of the amino acid sequence of the N-terminal region between NMT1 and NMT2 is 41%, which is much less than that of the catalytic region (Fig. 1A) . Additionally, it has been suggested that each NMT isozyme has a specific role in vivo. [14] [15] [16] [17] We therefore hypothesized that the lower identity of the N-terminal region between NMT1 and NMT2 is associated with the specific role of each isozyme at the ribosome. It was then examined whether the expressions of NMT1DC and NMT2DC can affect the ribosomal localization of endogenous NMT1 and NMT2. After subcellular fractionation, the endogenous NMT1 and NMT2 were detected by western immunoblot analysis using each NMT antibody as described in Materials and Methods. Since molecular weights of endogenous NMTs and NMTDC mutants 2020 Vol. 33, No. 12
Fig. 2. Distributions in Ribosome and Cytosol of NMTDC Mutants with or without K Box
Schematic representation of mutated NMT constructs used in the study (A). HEK293 cells were transfected with DNA for NMT1DC, NMT2DC, NMT1DCDK, or NMT2DCDK (B). HEK293 cells were also transfected with DNA for NMT1, NMT2, NMT1DK, or NMT2DK (C). Forty-eight hours post-transfection, the cells were lysed and subjected to subcellular fractionation to isolate the ribosomal and cytosolic fractions, followed by Western blot analysis to detect the NMT mutants, as described in Fig. 1. were 57 kDa and 16-17 kDa, respectively, it could be distinguished between the endogenous NMTs and the mutants in the western blot analysis using each anti-NMT isozyme specific antibody. As shown in the result of the mock transfected HEK293 cells in Fig. 3 , the amounts of endogenous NMT isozymes in the ribosomal fraction were relatively larger than those in the cytosolic fraction. The amount of endogenous NMT1 in the ribosomal fraction relatively decreased with the expression of NMT1DC. The expression of NMT2DC was also associated with partial decrease of the relative amount of endogenous NMT1 in ribosomal fraction; on the other hand, the amount of endogenous NMT2 in the ribosomal fraction relatively decreased with the expression of NMT2DC but not of NMT1DC. Additionally, no effect of NMT1DCDK or NMT2DCDK, which exclusively localizes in the cytosol, on the ribosomal localization of endogenous NMT isozymes was observed (Fig. 3) . The results suggest that NMT1DC and NMT2DC compete with endogenous NMT1 and endogenous NMT2 for the binding to the ribosome, respectively.
Taken together, the K box is thought to be essential for the binding of NMT1 and NMT2 to the ribosome, whereas the N-terminal region except the K box, which shows a low identity between NMT1 and NMT2, may contribute to the specific binding of each isozyme to the ribosome. While NMTDC mutants could bind to ribosome mediated by the K box, endogenous NMTs could bind to ribosome mediated by not only the K box but also interaction between catalytic region and N-terminal peptide of substrate protein under synthesis on the ribosome. Taking this possibility to consideration, the affinity of NMTDC mutants to ribosome might not be comparable to that of the endogenous NMTs.
We confirmed the importance of the N-myristoylation of Pr55 gag8) and Nef 21) for the production of HIV-1 virions from HEK293 cells. As shown in Fig. 4A , the level of viral production from HEK293 cells transfected with proviral DNA for HIV-1 with a G2A mutation in the N-terminus of Pr55 gag (gagG2A) or Nef (nefG2A) was about 20% or 50% of that of the HIV-1 wild type (WT). Furthermore, the level of production of HIV-1 with G2A mutations in both Pr55 gag and Nef (gagG2A/nefG2A) was similar to that of HIV-1 gagG2A. The effect of gagG2A on the reduction in the level of viral production was stronger than that of nefG2A.
siRNA using studies have suggested that NMT1 and NMT2 are at least closely associated with Pr55 gag and Nef, respectively, in HIV-1 replication. 16, 17) In other words, these results indicate that the production of HIV-1 WT depends on both NMT1 and NMT2, whereas the production of HIV-1 nefG2A depends on mainly NMT1. Since the competition of NMT1DC and NMT2DC with endogenous NMT isozymes for the targeting to the ribosome showed isozyme specificity (Fig. 3) , we asked whether the each mutant could also affect the HIV-1 production mediated by each endogenous ribosomal NMT isozyme. To address this question, HEK293 cells expressed with or without NMT1DC or NMT2DC were transfected with proviral DNA for HIV-1 WT or HIV-1 nefG2A and the level of viral production in the supernatant was measured. As shown in Figs. 4B and C, the level of HIV-1 WT production significantly decreased with the expression of either NMT1DC or NMT2DC, compared with that of the control. The level of HIV-1 nefG2A production significantly decreased with the expression of NMT1DC, which reduction level was similar to the case of HIV-1 WT. On the other hand, the effect of expression of NMT2DC on reduction of HIV-1 nefG2A production was less than that of HIV-1 WT. The results suggest that the production of HIV-1 WT is associated with both NMT1 and NMT2, whereas the production of HIV-1 nefG2A is mainly associated with NMT1, whose relations were similar to the that in the case of siRNA using previous studies. 16, 17) Almost no effects of coexpression of NMT1DC or NMT2DC on productions of HIV-1 gagG2A and HIV-1 gagG2A/nefG2A were expectedly observed (Figs. 4D, E) , which viruses have essentially extreme low production competence due to non N-myristoylation of Pr55 gag (Fig. 4A ). The expression of each NMTDC mutant in each case was verified by western blot analysis (Fig. 4D) .
Altogether, it is thought that NMT1DC or NMT2DC specifically affects endogenous NMT1 or NMT2 by the competition of the binding site on the ribosome, which might lead to miss the cotranslational N-myristoylation of the nascent peptides of Pr55 gag by NMT1 or Nef by NMT2 in the ribosome, although it has not been confirmed whether the N-myristoylation of Pr55 gag or Nef is actually affected. Alternatively, it is also thought that the NMTDC mutants might affect the viral production mediated by host N-myristoyl proteins.
In current HIV-1 therapy, the appearance of drug resistant HIV-1 is a serious problem. 22) One of the fundamental reasons is the targeting of viral factors. It has therefore been The ribosomal and cytosolic fractions were isolated from HEK293 cells expressing NMT1DC, NMT2DC, NMT1DCDK, or NMT2DCDK. Each endogenous NMT isozyme in both fractions was detected by Western blot analysis, as described in Fig. 1. proposed that the host factors required for HIV-1 replication could also become potential therapeutic targets.
23) The Nmyristoylation of both Pr55 gag and Nef is almost completely conserved in extremely diverse HIV-1, suggesting that the inhibition of NMT, especially the Pr55 gag -associated ribosomal NMT1 isozyme, is one of the most attractive targets against HIV-1. Since it is predicted that approximately 0.5% of all proteins in the human genome are N-myristoylated, 24) it should be investigated how the inhibition of targeting of NMT to ribosome could affect the other host N-myristoylated proteins, for example src family kinases and small G proteins. To accomplish such a strategy, the specific blockage of NMT isozyme targeting to the ribosome could become a novel therapeutic strategy for HIV-1 diseases.
